ロード中...
Gut Microbiota Changes in Patients With Major Depressive Disorder Treated With Vortioxetine
Vortioxetine hydrobromide is a common clinical medication for major depressive disorder (MDD). However, it remains unclear whether vortioxetine hydrobromide acts by affecting the structure and composition of gut microbiota. Here, we analyzed fecal samples from 28 healthy controls (HCs) and 26 patien...
保存先:
| 出版年: | Front Psychiatry |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138160/ https://ncbi.nlm.nih.gov/pubmed/34025474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2021.641491 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|